These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 10546408)
1. Comparison of two non-absorbable antibiotics for treatment of bacterial enteritis in children. Beseghi U; De'Angelis GL Eur Rev Med Pharmacol Sci; 1998; 2(3-4):131-6. PubMed ID: 10546408 [TBL] [Abstract][Full Text] [Related]
2. An open, controlled study of two non-absorbable antibiotics for the oral treatment of paediatric infectious diarrhoea. Frisari L; Viggiano V; Pelagalli M Curr Med Res Opin; 1997; 14(1):39-45. PubMed ID: 9524792 [TBL] [Abstract][Full Text] [Related]
3. A combination of rifaximin and neomycin is most effective in treating irritable bowel syndrome patients with methane on lactulose breath test. Low K; Hwang L; Hua J; Zhu A; Morales W; Pimentel M J Clin Gastroenterol; 2010 Sep; 44(8):547-50. PubMed ID: 19996983 [TBL] [Abstract][Full Text] [Related]
4. Comparative antibiotic efficacy studied by probit analysis of clinical data. Fici F; Del Vecchio F; Apolito A Chemotherapy; 1978; 24(2):112-7. PubMed ID: 620610 [No Abstract] [Full Text] [Related]
5. Rifaximin treatment of pathogen-negative travelers' diarrhea. DuPont HL; Haake R; Taylor DN; Ericsson CD; Jiang ZD; Okhuysen PC; Steffen R J Travel Med; 2007; 14(1):16-9. PubMed ID: 17241249 [TBL] [Abstract][Full Text] [Related]
6. Double-blind, placebo-controlled antibiotic treatment study of small intestinal bacterial overgrowth in children with chronic abdominal pain. Collins BS; Lin HC J Pediatr Gastroenterol Nutr; 2011 Apr; 52(4):382-6. PubMed ID: 21240023 [TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea. Taylor DN; Bourgeois AL; Ericsson CD; Steffen R; Jiang ZD; Halpern J; Haake R; Dupont HL Am J Trop Med Hyg; 2006 Jun; 74(6):1060-6. PubMed ID: 16760520 [TBL] [Abstract][Full Text] [Related]
11. [Double-blind study of the bacitracin-neomycin combination in the treatment of acute bacterial enteritis]. Caruso D; De Martino G; Gatti A; Iardino V Clin Ter; 1978 Apr; 85(1):35-45. PubMed ID: 657743 [No Abstract] [Full Text] [Related]
13. Treatment of travelers' diarrhea: randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone. Dupont HL; Jiang ZD; Belkind-Gerson J; Okhuysen PC; Ericsson CD; Ke S; Huang DB; Dupont MW; Adachi JA; De La Cabada FJ; Taylor DN; Jaini S; Martinez Sandoval F Clin Gastroenterol Hepatol; 2007 Apr; 5(4):451-6. PubMed ID: 17382603 [TBL] [Abstract][Full Text] [Related]
14. Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children. Rahman A; Rizwan S; Waycaster C; Wall GM Clin Ther; 2007 Sep; 29(9):1950-6. PubMed ID: 18035194 [TBL] [Abstract][Full Text] [Related]
15. Effects of rifaximin on indomethacin-induced intestinal damage in guinea-pigs. Ciobanu L; Taulescu M; Prundus R; Diaconu B; Andreica V; Catoi C; Pascu O; Tantau M Eur Rev Med Pharmacol Sci; 2014; 18(3):344-51. PubMed ID: 24563433 [TBL] [Abstract][Full Text] [Related]
17. Effects of daily oral administration of rifaximin and neomycin on faecal aerobic flora in rats. Miglioli PA; Allerberger F; CalabrĂ² GB; Gaion RM Pharmacol Res; 2001 Nov; 44(5):373-5. PubMed ID: 11712867 [TBL] [Abstract][Full Text] [Related]
18. A double-blind comparison of two different treatments for acute enteritis in adults. Camarri E; Belvisi A; Guidoni G; Marini G; Frigerio G Chemotherapy; 1981; 27(6):466-70. PubMed ID: 7028412 [No Abstract] [Full Text] [Related]
19. In vitro activity and fecal concentration of rifaximin after oral administration. Jiang ZD; Ke S; Palazzini E; Riopel L; Dupont H Antimicrob Agents Chemother; 2000 Aug; 44(8):2205-6. PubMed ID: 10898704 [TBL] [Abstract][Full Text] [Related]
20. Use and safety of rifaximin in children with inflammatory bowel disease. Muniyappa P; Gulati R; Mohr F; Hupertz V J Pediatr Gastroenterol Nutr; 2009 Oct; 49(4):400-4. PubMed ID: 19668011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]